INFLUENCE OF INHIBITORS OF EICOSANOID METABOLISM ON PROLIFERATION OF RAT HEPATOMA-CELLS AND ON TUMOR-HOST INTERACTION

被引:10
作者
CYRAN, JA
LYSZ, TW
LEA, MA
机构
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT BIOCHEM,NEWARK,NJ 07103
[2] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT SURG,NEWARK,NJ 07103
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1990年 / 39卷 / 04期
关键词
D O I
10.1016/0952-3278(90)90011-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of eicosanoids on the proliferation of hepatoma (HTC) cells was studied in culture and in tumor-bearing rats. The cells in culture demonstrated a capacity to metabolize arachidonic acid to eicosanoids including thomboxane B2 and the prostaglandins E2 and F2αa. An effect of these eicosanoids on cell proliferation was suggested by the decreased cell division seen with an inhibitor of cyclooxygenase, flurbiprofen. A biphasic effect on the proliferation of HTC cells was observed with increasing concentrations of prostaglandin F2α. These studies were extended to tumor-bearing rats where inhibitory effects on the early stages of tumor growth were seen with flurbiprofen. Bleeding times were decreased in tumor-bearing rats but were restored to control values by treatment with flurbiprofen and an inhibitor of thromboxane synthetase, OKY 046. These drugs and a thromboxane/endoperoxide receptor antagonist, SQ 29, 548, were not observed to have statistically significant effects on isotope-labeled water distribution but they had substantial effects on the maintenance of body weight by tumor-bearing rats. The data suggested that the cachexia of tumor-bearing animals may be mediated at least in part by the action of eicosanoids. © 1990.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 29 条
[1]   CANCER GROWTH, RESPONSE TO TREATMENT AND SURVIVAL TIME IN MICE - BENEFICIAL EFFECT OF THE PROSTAGLANDIN SYNTHESIS INHIBITOR FLURBIPROFEN [J].
BENNETT, A ;
HOUGHTON, J ;
LEAPER, DJ ;
STAMFORD, IF .
PROSTAGLANDINS, 1979, 17 (02) :179-191
[3]  
CYRAN J, 1986, FASEB J, V45, P1813
[4]  
DAYER JM, 1985, J EXP MED, V162, P263
[5]   EVIDENCE THAT PROSTAGLANDINS DO NOT HAVE A ROLE IN THE CYTOSTATIC ACTION OF ANTI-INFLAMMATORY DRUGS [J].
DEMELLO, MCF ;
BAYER, BM ;
BEAVEN, MA .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (03) :311-318
[6]   PROTECTIVE EFFECTS OF THROMBOXANE-A2 SYNTHETASE INHIBITORS ON ENDOTOXIN-SHOCK [J].
FUKUMOTO, S ;
TANAKA, K .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1983, 11 (02) :179-188
[7]   THROMBOXANES AND PROSTACYCLIN - POSITIVE AND NEGATIVE MODULATORS OF TUMOR-GROWTH [J].
HONN, KV ;
MEYER, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 102 (04) :1122-1129
[8]   HIGHLY SELECTIVE INHIBITORS OF THROMBOXANE SYNTHETASE .1. IMIDAZOLE DERIVATIVES [J].
IIZUKA, K ;
AKAHANE, K ;
MOMOSE, DI ;
NAKAZAWA, M ;
TANOUCHI, T ;
KAWAMURA, M ;
OHYAMA, I ;
KAJIWARA, I ;
IGUCHI, Y ;
OKADA, T ;
TANIGUCHI, K ;
MIYAMOTO, T ;
HAYASHI, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (10) :1139-1148
[9]   INDOMETHACIN IN SUBMICROMOLAR CONCENTRATIONS INHIBITS CYCLIC AMP-DEPENDENT PROTEIN-KINASE [J].
KANTOR, HS ;
HAMPTON, M .
NATURE, 1978, 276 (5690) :841-842
[10]   ANTITUMOR-ACTIVITY IN A RAT MAMMARY ADENOCARCINOMA - THE EFFECT OF CYCLOOXYGENASE INHIBITORS AND IMMUNIZATION AGAINST PROSTAGLANDIN-E2 [J].
KARMALI, RA ;
MARSH, J .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1985, 20 (03) :283-286